{"id":"tp-39049","type":"article-newspaper","title":"Gilead Agrees to Acquire PepStar’s Oral IL-23R Program for $1.275B","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/39049","datePublished":"2026-10-23T14:31:41.000Z","dateModified":"2026-10-23T14:31:41.000Z","language":"en","abstract":"Lead candidate HCXT-2001 is in Phase 1. Closing is expected in the fourth quarter of 2026, subject to customary conditions.","section":"Business","references":[]}